THYMOGLOBULIN DIN 02246805
Health Canada record
| Active ingredient(s) | ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | L04AA04 ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) |
| Original market date | 06-May-2003 |
| Current status date | 06-May-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14337 | 2013-05-06 | New Drug Submission (NDS) | Manufacturer name change |
| 5316 | 2004-09-03 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 191 | 2002-11-20 | New Drug Submission (NDS) |